Skip to main content
DAEWOONG PHARMA logo

DAEWOONG PHARMA — Investor Relations & Filings

Ticker · 069620 ISIN · KR7069620003 KO Manufacturing
Open in API
Filings indexed 380 across all filing types
Latest filing 2025-07-30 Regulatory Filings
Country KR South Korea
Listing KO 069620

About DAEWOONG PHARMA

http://crm.daewoong.co.kr/eng/main

Daewoong Pharma is an R&D-centric pharmaceutical company specializing in the development, manufacturing, and commercialization of medical products. The company's portfolio encompasses prescription drugs, with a focus on gastrointestinal and endocrine therapies, alongside biologics, healthcare products, and active pharmaceutical ingredients (APIs). A core tenet of its business model is 'Open Collaboration,' actively seeking partnerships with academic and industry entities to foster innovation. Daewoong Pharma's research efforts are directed towards breakthrough therapies, utilizing advanced drug delivery technologies and expertise in biologics. The company also offers integrated formulation and manufacturing services, supporting partners from initial development to commercial production.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Daewoong Pharmaceutical regarding the voluntary withdrawal of a product license application (Nabota) in China. It is a formal disclosure of a material business event submitted to the Korea Exchange (KRX). Since it does not fit into specific categories like M&A, dividends, or financial reports, and serves as a general regulatory announcement of a material corporate event, it is classified as a Regulatory Filing (RNS).
2025-07-30 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the National Pension Service's (a major shareholder) changes in share ownership of Daewoong Pharmaceutical (069620) over a specific period. This type of filing is a standard regulatory disclosure for major shareholders to report changes in their holdings, which falls under the 'Major Shareholding Notification' category.
2025-07-03 Korean
지속가능경영보고서등관련사항(자율공시)
Report Publication Announcement Classification · 100% confidence The document is a short regulatory filing (2,462 characters) that serves as an announcement for the publication of the '2025 Sustainability Report'. It explicitly states that the report is available on the company website and provides a summary of the report's contents rather than being the full report itself. According to the 'Menu vs Meal' rule, this is a Report Publication Announcement (RPA).
2025-06-30 Korean
기업지배구조보고서공시
Governance Information Classification · 100% confidence The document is a 'Corporate Governance Report' (기업지배구조보고서) for Daewoong Pharmaceutical. It details the company's governance structure, shareholder rights, board composition, and internal control policies. This type of report is a standard regulatory filing in South Korea, specifically categorized under Governance Information (CGR) in the provided schema.
2025-06-02 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. This type of filing is a standard regulatory disclosure for insider trading or changes in share ownership by company directors and major shareholders. Based on the provided definitions, this falls under 'Director's Dealing' (DIRS).
2025-05-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including acquisition methods like market purchases, inheritance, and management changes. This corresponds to the 'Major Shareholding Notification' category.
2025-05-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.